While many of us had the chance to enjoy a summer vacation, psychedelic researchers were hard at work. We’ve rounded up key papers from the past 2 months 👇 Psychedelic Research Recap July & August 2022 While many of us had the chance to enjoy a vacation this summer, psychedelic researchers continued their hard work…blossomanalysis.com Results from the first trial using psilocybin to treat alcoholism are promising.

One lawyer is shining his light on the dark underworld of psychedelic patents Meet @calyxlaw(Graham Pechenik), the soft-spoken champion of psychedelic intellectual property Before founding Calyx Law in 2016, Graham defended — and challenged — patents for over a decade His work ranged from challenging Monsanto GMO patents to representing…

There are a million psychedelic conferences happening this year. Ok, maybe fewer, but here are the next 16 you might want to visit: (in chronological order) Let me know in the comments which ones I’ve overlooked. 1 The Psychedelic Assembly | 10–11 Sep Max 100 people, focus on making connections…

By next year, MAPS is expected to get FDA approval for MDMA-assisted therapy. But MAPS isn’t the only one developing MDMA or similar (analogue) molecules. Today, the Australian billionaire Andrew Forrest, through Tenmile investments, announced investing $250 million in health tech companies. One company receiving those funds is Emyria. Making novel psychedelics down under Emyria…

Amy Emerson is the CEO of MAPS PBC. Here is the story of how she got there & where she’s taking MDMA-AT for PTSD next. Some quick background if you’re unfamiliar with @MAPSPBC The organisation is wholly owned by MAPS (the non-profit) 140 people work there vs 45 at MAPS …

We’ve read over 50 psychedelic books Most do a poor job of introducing new people to psychedelics The Psychedelic Handbook by Dr Rick Strassman — out today — may quickly become the book to recommend 3 reasons why 👇 1. Concise & Clear You can’t not love Michael Pollan’s prose…

Researchers associated with Mindbloom just published an article arguing that at-home ketamine-assisted therapy is not only safe but led to improvements (<50%) in depression and anxiety in 62% of participants. But wait, haven’t all read that maybe the services provided by Mindbloom were faced with “organizational difficulties, long wait times…

Psychedelic therapy is going mainstream — it won’t be long before these therapies are rolled out in clinics across the globe once the regulations around these substances are changed. Many believe that psychedelic therapy is the solution to the global mental health crisis. While it is hard to deny these…

Psychedelics are poised to be a solution to the global mental health crisis, and eventually, psychedelic therapy is likely to become an accessible treatment, so we should start planning now. While clinical trials are progressing with positive results, it remains unclear how or if these results will translate into the…